EarningsQ2 2024 Earnings Report

Rhythm Pharmaceuticals (RYTM) Q2 2024 Earnings Report

1 Followers

MX:RYTM Q2 2024 EPS Results

Actual EPS-$9.47

Consensus EPS-$12.21

Beat/MissBeat by +$2.74

One Year Ago EPS-$14.12

Actual Revenue$500.71M

Expected Revenue$495.75M

Beat/MissBeat by +$4.96M

YoY Revenue Growth+51.28%

QuarterQ2 2024

Date08/06/2024

TimeBefore Open

Conference CallTuesday, August 6, 2024

MX:RYTM Upcoming Earnings

Rhythm Pharmaceuticals's next earnings date is estimated for November 10, 2026, based on past reporting schedules.

MX:RYTM Q2 2024 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 10, 2026	2026 (Q3)	-12.45 / -	-14.12	―
Aug 04, 2026	2026 (Q2)	-13.90 / -12.57	-12.915	2.67% (+0.34)
May 05, 2026	2026 (Q1)	-14.15 / -14.29	-13.948	-2.47% (-0.34)
Feb 26, 2026	2025 (Q4)	-13.86 / -12.57	-12.398	-1.39% (-0.17)
Nov 04, 2025	2025 (Q3)	-12.19 / -14.12	-12.57	-12.33% (-1.55)
Aug 05, 2025	2025 (Q2)	-11.54 / -12.91	-9.471	-36.36% (-3.44)
May 07, 2025	2025 (Q1)	-11.95 / -13.95	-40.466	65.53% (+26.52)
Feb 26, 2025	2024 (Q4)	-11.95 / -12.40	-12.054	-2.86% (-0.34)
Nov 05, 2024	2024 (Q3)	-13.86 / -12.57	-13.087	3.95% (+0.52)
Aug 06, 2024	2024 (Q2)	-12.21 / -9.47	-14.12	32.93% (+4.65)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed